Heavyweights Pfizer, Novartis, and Lilly, and the smaller biopharma, Incyte had TV ads during the Oscars on Sunday. These ads weren’t cheap. Thirty second spots ran anywhere from $1.7 - $2.2 million.
Roche said Wednesday that an experimental cancer immunotherapy directed against a target called TIGIT failed to slow the progression of a less common but aggressive type of lung cancer.
Anyone 50 years and older could soon be eligible for a second booster dose of the Moderna or Pfizer-BioNtech COVID-19 vaccine. The FDA is expected to authorize the additional booster shots without holding a meeting of its independent vaccine advisors.